Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Ovarian Neoplasms × Magnetic Resonance Imaging × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Prostatic Neoplasms 3 Head and Neck Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Urinary Bladder Neoplasms 1 Thyroid Nodule 1 Spinal Cord Tumor of Cervical Spine 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Retinoblastoma 1 Pathologic Complete Response 1 Parotid Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Multiple Pulmonary Nodules 1 Mouth Neoplasms 1 Lymphoma 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Glioma 1 Esophageal Neoplasms 1 Disease 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Calcinosis 1 Adenocarcinoma Of Esophagus 1

Interventions

Carboplatin 35 Paclitaxel 34 Bevacizumab 13 olaparib 12 niraparib 11 apatinib 11 Cisplatin 10 liposomal doxorubicin 9 Gemcitabine 9 Cyclophosphamide 8 fludarabine 7 Hyperthermic Intraperitoneal Chemotherapy 7 Etoposide 7 pembrolizumab 6 Topotecan 5 Drug Therapy 5 fluzoparib 4 anlotinib 4 Surveys and Questionnaires 4 Ifosfamide 4 Doxorubicin 4 Docetaxel 4 Albumin-Bound Paclitaxel 4 oregovomab 3 Taxes 3 Poly(ADP-ribose) Polymerase Inhibitors 3 Cytoreduction Surgical Procedures 3 Amplified Fragment Length Polymorphism Analysis 3 1-dodecylpyridoxal 3 pazopanib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03526809 2018-05-16

MISSION-ovary

Cambridge University Hospitals NHS Foundation Trust

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡